Prices don’t reflect anything on resource or tech. They reflect...

Prices don’t reflect anything on resource or tech.

They reflect the lack of funding which must be dipping below $3 mill and the need for fundraising.

They may stagger funding through to next assay results but that will be more of the same re resource. Met results are important but many are chasing and nothing is convincing yet.

So knowing all this what will change the capping of this stock? A corner stone investor and overseas partner to take future product should do that. But when.

As I’ve said before BH should be overseas selling this project potential not giving ten minute presentations to nobody brokers.

Hazelden has to get on a plane ASAP otherwise we are on a boat to nowhere.